Avg closing price
Price range

10 Jim Simons Athira Pharma Trades

Jim Simons acquired 265 Thousand Athira Pharma shares worth $679 Thousand. That's 0.00% of their equity portfolio (2486th largest holding). The first Athira Pharma trade was made in Q3 2021. Since then Jim Simons bought shares four more times and sold shares on five occasions. The investor's estimated purchase price is $858 Thousand, resulting in a loss of 21%.

Avg closing price
Price range
Sold 6.2% shares (-17.5 Thousand shares) Q4 2023
Avg closing price $1.77
Price range $1.39 - $2.46
Sold 35.5% shares (-156 Thousand shares) Q3 2023
Avg closing price $2.56
Price range $1.90 - $3.16
Increased shares by 40.7% (+127 Thousand shares) Q2 2023
Avg closing price $2.85
Price range $2.36 - $3.59
Increased shares by 279.9% (+230 Thousand shares) Q1 2023
Avg closing price $3.22
Price range $2.26 - $4.22
Sold 65.1% shares (-153 Thousand shares) Q4 2022
Avg closing price $3.15
Price range $2.76 - $3.71
New holding (+235 Thousand shares) Q3 2022
Avg closing price $3.45
Price range $2.93 - $3.96
Sold -37.4 Thousand shares Q2 2022
Avg closing price $9.16
Price range $2.74 - $13.43
Sold 67.1% shares (-76.4 Thousand shares) Q1 2022
Avg closing price $10.54
Price range $8.96 - $13.51
Increased shares by 115.8% (+61.1 Thousand shares) Q4 2021
Avg closing price $12.64
Price range $9.17 - $16.39
New holding (+52.7 Thousand shares) Q3 2021
Avg closing price $10.18
Price range $9.15 - $11.09

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!